Serious discordance between MTBC trace positivity by Xpert MTB/RIF ultra and follow up culture

Authors

  • Partha Roy Consultant Microbiology and Virology, Oncquest Laboratories Ltd, New Delhi, India
  • Ankita Anand Consultant Microbiology and Virology, Oncquest Laboratories Ltd, New Delhi, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20203482

Keywords:

CBNAAT, GeneXpert, Trace, Ultra, Xpert MTB/RIF

Abstract

Authors wish to report a major discordance between Xpert MTB/RIF Ultra Trace positivity (GeneXpert, Cepheid) and follow up by liquid culture.

References

World Health Organization. Policy update: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. 2013.

World Health Organization. Rapid Implementation of the Xpert MTB/RIF diagnostic test. Available at: http://www.stoptb.org/wg/gli/assets/documents/. Accessed 28 January 2020.

New Laboratory Diagnostic Tools for Tuberculosis Control. WHO; 2008. Available at: http://www.stoptb. org/assets/ documents/global/ retooling/Diagnostic_Brochure_Print_2009 _Jan_29.pdf. Accessed 28 January 2020.

Opota O, Zakham F, Mazza-Stalder J, Nicod L, Greub G, Jaton K. Added Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a Low-Prevalence Setting. J Clin Microbiol, 2019:57(2);e01717-8.

Kendall EA, Schumacher SG, Denkinger CM, Dowdy DW. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study. PLoS Med. 2017;14(12):e1002472.

Downloads

Published

2020-07-24

How to Cite

Roy, P., & Anand, A. (2020). Serious discordance between MTBC trace positivity by Xpert MTB/RIF ultra and follow up culture. International Journal of Research in Medical Sciences, 8(8), 3152–3153. https://doi.org/10.18203/2320-6012.ijrms20203482

Issue

Section

Letter to the Editor